Compare VAC & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VAC | TWST |
|---|---|---|
| Founded | 1984 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.6B |
| IPO Year | N/A | 2018 |
| Metric | VAC | TWST |
|---|---|---|
| Price | $57.49 | $31.73 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 8 | 8 |
| Target Price | ★ $64.00 | $44.88 |
| AVG Volume (30 Days) | 820.9K | ★ 1.1M |
| Earning Date | 11-05-2025 | 02-02-2026 |
| Dividend Yield | ★ 5.48% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.58 | N/A |
| Revenue | ★ $3,358,000,000.00 | $376,572,000.00 |
| Revenue This Year | $54.51 | $15.19 |
| Revenue Next Year | $2.59 | $15.10 |
| P/E Ratio | $12.76 | ★ N/A |
| Revenue Growth | 5.13 | ★ 20.32 |
| 52 Week Low | $44.58 | $23.30 |
| 52 Week High | $91.18 | $55.33 |
| Indicator | VAC | TWST |
|---|---|---|
| Relative Strength Index (RSI) | 52.68 | 48.89 |
| Support Level | $57.53 | $30.21 |
| Resistance Level | $58.71 | $35.39 |
| Average True Range (ATR) | 1.66 | 1.60 |
| MACD | 0.19 | -0.11 |
| Stochastic Oscillator | 58.66 | 26.93 |
Marriott Vacations Worldwide Corp functions in the United States leisure industry. It owns and manages a cluster of resorts and accommodation facilities under trademarks like Marriott Vacation Club, Grand Residencies, and The Ritz-Carlton Destination Club predominantly in the United States. Some of its properties are also spread across Europe and Asia Pacific. Marriott's majority revenue components include the sale of vacation ownership products such as luxurious vacation packages. In addition, it offers purchase money financing to the end users of its core services. The company operates in two reportable segments: Vacation Ownership and Exchange & Third-Party Management. The majority of revenue is derived from the Vacation Ownership segment.
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.